Sign in

CIK 0000749647

  • Non-accelerated filer
  • Smaller reporting company

Imunon, Inc.

Sign in to watch
Ticker
IMNN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
521256615
Phone
+1 609-896-9100
Business address
997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NJ, 08648
Former names
CELSION CORP, Celsion CORP, CHEUNG LABORATORIES INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale General Counsel and Corp Sec sold 920 shares at $1.88 ($1,730)
  3. 4 Grant or award Chief Medical Officer acquired 1,308 shares (grant or award)
  4. 4 Grant or award President and CEO acquired 2,534 shares (grant or award)
  5. 4 Grant or award Chief Medical Officer acquired 21,896 shares (grant or award)
  6. 4 Open-market sale General Counsel and Corp Sec sold 11,800 shares at $1.75 ($20,674)
  7. 4 Grant or award Executive Chairman of Board acquired 42,519 shares (grant or award)
  8. 4 Grant or award President and CEO acquired 67,150 shares (grant or award)
  9. 4 Grant or award Executive Chairman of Board acquired 4,629 shares (grant or award)
  10. 4 Grant or award President and CEO acquired 1,803 shares (grant or award)
  11. 4 Grant or award Executive Chairman of Board acquired 4,089 shares (grant or award)
  12. 4 Grant or award President and CEO acquired 1,593 shares (grant or award)
  13. 4 Grant or award Executive Chairman of Board acquired 3,484 shares (grant or award)
  14. 4 Grant or award Director acquired 5,557 shares (grant or award)
  15. 4 Grant or award Director acquired 11,148 shares (grant or award)
  16. 4 Grant or award Director acquired 5,011 shares (grant or award)
  17. 4 Grant or award Director acquired 10,330 shares (grant or award)
  18. 4 Grant or award President and CEO acquired 1,491 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 3 of 30 · 594 filings